NeOnc Technologies Holdings, Inc. Common Stock

NTHI
Sell Open
Signal type
Sell
Status
Open
Open Price
$8.48
Stop Loss
$10.54
Performance
36.44%
Days Open
33

Signal Setup

Signal Type Sell
Status Open
Open Date Mar 13, 2026
Open Price $8.48
Stop Loss $10.54
Timespan Day

Company Profile

Name NeOnc Technologies Holdings, Inc. Common Stock
Ticker NTHI
Market Cap $67.93M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $5.39
List Date Mar 26, 2025
Description

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").